Live Breaking News & Updates on Chief Scientific Officer Mikael Dolsten

Stay updated with breaking news from Chief scientific officer mikael dolsten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pfizer drops plan to study twice-daily obesity pill in late-stage studies

(Reuters) -Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after most patients dropped out of an earlier trial with high rates of side effects such as nausea and vomiting. Although Pfizer has a once-daily version of the weight-loss pill in the works, the decision still marks a blow to its ambition of entering a booming market that analysts expect to be worth $100 billion by the end of the decade. Pfizer said the drug cut weight by as much as 13% at 32 weeks in adults with obesity and without type 2 diabetes in a mid-stage trial. ....

New York , United States , Eli Lilly Mounjaro , Manas Mishra , Mikael Dolsten , Novo Nordisk Wegovy , Eli Lilly , Shinjini Ganguli , Novo Nordisk , Chief Scientific Officer Mikael Dolsten , Michael Erman , Nausea And Vomiting , Eli Lilly , Wice Daily Version , Side Effects ,

PFE Stock Slides After Pfizer's Latest Setback For Weight-Loss Drug

PFE Stock Slides After Pfizer's Latest Setback For Weight-Loss Drug
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Mikael Dolsten , Playing Catch Up For Weight Loss , Chief Scientific Officer Mikael Dolsten , Novo Nordisk , Eli Lilly ,

PFE Stock Slides After Pfizer's Latest Setback For Weight-Loss Drug

PFE Stock Slides After Pfizer's Latest Setback For Weight-Loss Drug
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Mikael Dolsten , Playing Catch Up For Weight Loss , Chief Scientific Officer Mikael Dolsten , Novo Nordisk , Eli Lilly ,

Pfizer, Flagship Pioneering to invest $100 million in drug discovery

Pfizer and Flagship Pioneering, a renowned venture firm known for incubating biotech companies like Moderna Inc, have announced a joint investment of $100 million. ....

Paul Biondi , Mikael Dolsten , Bristol Myers Squibb , Moderna Inc , Flagship Pioneering , Pioneering Medicines , Chief Scientific Officer Mikael Dolsten , Denali Therapeutics , Foghorn Therapeutics , Sana Biotechnology ,